A Catalytic Role for Proangiogenic Marrow-Derived Cells in Tumor Neovascularization
- 1 March 2008
- journal article
- editorial
- Published by Elsevier BV in Cancer Cell
- Vol. 13 (3), 181-183
- https://doi.org/10.1016/j.ccr.2008.02.016
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and InvasionCancer Cell, 2008
- Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic CellsCancer Cell, 2008
- A Few to Flip the Angiogenic SwitchScience, 2008
- Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesisProceedings of the National Academy of Sciences of the United States of America, 2007
- VEGF-Induced Adult Neovascularization: Recruitment, Retention, and Role of Accessory CellsCell, 2006
- Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesisCancer Cell, 2004
- Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrinCancer Cell, 2003
- Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-LigandCell, 2002
- Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growthNature Medicine, 2001
- Growth factor–induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagenBlood, 2001